advertisement
Lu F 10
Showing records 1 to 10 | Display all abstracts from Lu F98833 Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study
Wirta DL
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 240-251
99098 Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
He C
Oxidative medicine and cellular longevity 2022; 2022: 8063651
98833 Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study
Kuwayama Y
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 240-251
99098 Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Zhang G
Oxidative medicine and cellular longevity 2022; 2022: 8063651
98833 Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study
Lu F
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 240-251
99098 Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Fu J
Oxidative medicine and cellular longevity 2022; 2022: 8063651
98833 Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study
Shao H
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 240-251
99098 Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Zhang R; Li A
Oxidative medicine and cellular longevity 2022; 2022: 8063651
98833 Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study
Odani-Kawabata N
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 240-251
99098 Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Liu D; Li B; Chen Y; Deng B; Shuai P; Lu F
Oxidative medicine and cellular longevity 2022; 2022: 8063651
